International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson’s Disease Clinical Trial – Nasdaq
|
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
Nasdaq 13, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the positive six months interim … |
